Originally launched in April 2020 with the aim of identifying risk factors and biomarkers associated with COVID-19 severity in the adult population, Predi-COVID has now officially been extended to children. The study, coordinated by the Luxembourg Institute of Health (LIH) and carried out under the aegis of the Research Luxembourg COVID-19 Task Force, will particularly benefit from the collaboration with the Centre Hospitalier de Luxembourg (CHL) for the recruitment of younger children.

WEBINAR: Lecture series in Infection & Immunity - "Genetic and immunological causes of life-threatening COVID-19" - Prof Jean-Laurent Casanova

WEBINAR: Lecture series Cancer Research: "Towards the molecular blood count: from small non-coding RNAs to single cell resolution immune system data" - Prof Andreas Keller

GEoPD 16th Annual Meeting

The National Centre of Excellence in Research on Parkinson’s Disease (NCER-PD) launches a nation-wide research survey on sleep behaviour disorders under the patronage of the Ministry of Health.

On February 9th, Erica Grant, doctoral candidate within the Eco-Immunology and Microbiome group of the LIH Department of Infection and Immunity (DII), was awarded the 2020 Pelican Grant by the Fondation du Pélican de Mie et Pierre Hippert-Faber. The grant will support her training and mobility activities in the context of her research project on the gut microbiome.

Several PhD candidates from the LIH Departments of Infection and Immunity (DII), Population Health (DoPH) and Oncology (DONC) contributed to “LUX:plorations”, an innovative series of catchy cartoons promoted by the Doctoral Education in Science Communication (DESCOM) project of the University of Luxembourg. The aim of the initiative? Explaining science and research to the lay public in a colourful and artistic way!

GOOD CLINICAL PRACTICE - Professional courses: How to write a clinical research protocol for a successful project

Based on the results of the large-scale testing programme run in Luxembourg, researchers show that asymptomatic SARS-CoV-2 carriers represent an important vector for transmission.